Skip to main content

Table 19 Laboratory outcomes after using antibiotics

From: Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy

1 week after admission

No. (Total n = 13,932)

No. (%)

WITH antibiotics n = 12,238 (%)

WITHOUT antibiotics n = 1498 (%)

Odds ratio (95% CI)

p value

Anemia (Hb < 12 g/dL)

12,646

3760 (29.7)

3432 (30.1)

328 (26.2)

1.21 (1.06–1.39)

0.004

Thrombocytosis (Platelet count > 180)

12,631

10,191 (80.7)

9211 (80.9)

980 (78.5)

1.16 (1.01–1.34)

0.036

Leukocytosis (Leukocytes > 10,000)

12,644

2401 (19.0)

2255 (19.8)

146 (11.7)

1.87 (1.56–2.23)

< 0.001

Leukopenia (Leukocytes < 4000)

11,150 (88.2)

10,073 (88.4)

1,077 (86.2)

1.22 (1.03–1.45)

0.020

Lymphopenia (Lymphocytes < 1300)

12,626

4811 (38.1)

4211 (37.0)

600 (48.2)

0.63 (0.56–0.71)

< 0.001

Evolution of inflammatory parameters associated with covid-19

 C-reactive protein > 50 mg/L

12,248

4049 (33.1)

3761 (34.0)

288 (24.3)

1.61 (1.40–1.85)

< 0.001

 Procalcitonin > 0.5 ng/mL

4907

606 (12.4)

575 (13.1)

31 (6.3)

2.25 (1.55–3.27)

< 0.001

 Ferritin > 274 mcg/L

6149

4967 (80.8)

4506 (81.7)

461 (73.2)

1.63 (1.35–1.97)

< 0.001

 Fibrinogen > 650 mg/dL

7852

2920 (37.2)

2602 (37.1)

318 (38.3)

0.95 (0.82–1.10)

0.50

 CK > 200 U/L

5775

697 (12.1)

657 (12.4)

40 (8.6)

1.50 (1.08–2.10)

0.017

 LDH > 300 U/L

11,264

5002 (44.4)

4593 (45.3)

409 (36.8)

1.42 (1.25–1.62)

< 0.001

 IL-6 > 4.3 pg/mL

2074

1593 (76.8)

1428 (76.9)

165 (75.7)

1.07 (0.77–1.49)

0.68

 D-Dimer > 250 ng/mL

9605

8367 (87.1)

7570 (87.8)

797 (81.2)

1.66 (1.40–1.97)

< 0.001